Physician profile
Sean E Keating
NPI 1457372161
$6,923.67
in general payments reported to CMS, 2019-2025
28 companies · $957 in 2025
The $957 reported for 2025 was more than what 79% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,155 · 2020: $562 · 2021: $1,056 · 2022: $1,374 · 2023: $1,055 · 2024: $765 · 2025: $957.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,850 · Travel and Lodging: $926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,850.35 |
| Travel and Lodging | $926.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,398.94 | 2021-2025 | |
| Smith+Nephew, INC. | $1,018.11 | 2019-2024 | Memofix Super Elastic Nitinol Staple System |
| Horizon Therapeutics Plc | $669.96 | 2019-2023 | Krystexxa |
| Organogenesis INC. | $400.40 | 2019-2022 | |
| Stryker Corporation | $329.09 | 2019-2020 | |
| Orthofix Medical, INC. | $315.72 | 2020-2023 | Physio-Stim |
| Integra Lifesciences Corporation | $283.92 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $275.74 | 2019-2023 | Activ.A.C., Abthera, Prevena |
| Abbott Laboratories | $254.26 | 2022-2024 | Octrode, Proclaim |
| Bioventus LLC | $235.21 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $161.05 | 2024 | |
| Next Science LLC | $153.88 | 2024 | Surgx, Xperience, Blastx |
| Acera Surgical, INC. | $149.03 | 2023 | Restrata Wound Matrix |
| Kerecis Limited | $147.42 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Heron Therapeutics, INC. | $132.00 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Oxygen Therapy INC. | $124.99 | 2022 | |
| Misonix INC | $124.00 | 2021 | |
| Paratek Pharmaceuticals, INC. | $121.36 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $119.51 | 2021 | |
| Innovation Technologies INC | $113.53 | 2021 | |
| Abbvie INC. | $110.60 | 2022 | |
| Melinta Therapeutics, LLC | $97.96 | 2021 | |
| Triad Life Sciences INC. | $92.31 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $22.84 | 2023 | Seglentis |
| Averitas Pharma INC. | $20.03 | 2023 | Qutenza |
| Amgen INC. | $19.58 | 2024 | Krystexxa |
| Grt US Holding, INC. | $19.07 | 2022 | |
| Merck Sharp & Dohme LLC | $13.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Keating listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.